Paper25757092
Luotonin-A based quinazolinones cause apoptosis and senescence via HDAC inhibition and activation of tumor suppressor proteins in HeLa cells.
Venkatesh R and 8 others. Eur J Med Chem, 2015. Cited by 22 papers, by iCite.
Cite this record
ConductScience Library. Luotonin-A based quinazolinones cause apoptosis and senescence via HDAC inhibition and activation of tumor suppressor proteins in HeLa cells. Papers, record 25757092. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25757092
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Luotonin-A based quinazolinones cause apoptosis and senescence via HDAC inhibition and activation of tumor suppressor proteins in HeLa cells.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Apoptosis | Major topic |
| Histone Deacetylase Inhibitors | Major topic |
| Histone Deacetylases | Major topic |
| Pyrroles | Major topic |
| Quinazolinones | Major topic |
| Quinones | Major topic |
| Cell Cycle | |
| Cellular Senescence | |
| Click Chemistry | |
| Enhancer of Zeste Homolog 2 Protein | |
| HeLa Cells | |
| Histone Deacetylase 1 | |
| Histone Deacetylase 2 | |
| Humans | |
| Inhibitory Concentration 50 | |
| K562 Cells | |
| MCF-7 Cells | |
| Molecular Docking Simulation | |
| Polycomb Repressive Complex 2 | |
| Tumor Suppressor Protein p53 | |
| Tumor Suppressor Proteins |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41504103 | Synthesis, Anticancer Evaluation, and Molecular Docking of Triazolylmethyl-Dihydroquinazolinyl Benzoate Derivatives as Potential PARP-1 Inhibitors. | Chem Biodivers | 2026 | https://conductscience.org/library/papers/41504103 | PubMed |
| 40999977 | Quinazolinone derivatives as potential anti‑tumor agents: Structural features and molecular mechanisms in inducing cell death (Review). | Int J Mol Med | 2025 | https://conductscience.org/library/papers/40999977 | PubMed |
| 40351067 | Pharmacological Evaluation of Bioisosterically Replaced and Triazole- Tethered Derivatives for Anticancer Therapy. | Med Chem | 2025 | https://conductscience.org/library/papers/40351067 | PubMed |
| 39443462 | Novel quinazolin-4-one based derivatives bearing 1,2,3-triazole and glycoside moieties as potential cytotoxic agents through dual EGFR and VEGFR-2 inhibitory activity. | Sci Rep | 2024 | https://conductscience.org/library/papers/39443462 | PubMed |
| 37226094 | Drug mechanism enrichment analysis improves prioritization of therapeutics for repurposing. | BMC Bioinformatics | 2023 | https://conductscience.org/library/papers/37226094 | PubMed |
| 35516563 | Recent advances in the pharmacological diversification of quinazoline/quinazolinone hybrids. | RSC Adv | 2020 | https://conductscience.org/library/papers/35516563 | PubMed |
| 34178647 | Insights Into the Function and Clinical Application of HDAC5 in Cancer Management. | Front Oncol | 2021 | https://conductscience.org/library/papers/34178647 | PubMed |
| 33634093 | Histone Deacetylase Inhibitors as Therapeutic Interventions on Cervical Cancer Induced by Human Papillomavirus. | Front Cell Dev Biol | 2020 | https://conductscience.org/library/papers/33634093 | PubMed |
| 31368626 | From molecular promise to preclinical results: HDAC inhibitors in the race for healthy aging drugs. | EMBO Mol Med | 2019 | https://conductscience.org/library/papers/31368626 | PubMed |
| 29086906 | Synthesis and anticancer activity of novel quinazolinone-based rhodanines. | Chem Cent J | 2017 | https://conductscience.org/library/papers/29086906 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CDKN2A | 1029 | PubTator's text mining | https://conductscience.org/library/genes/1029 | NCBI Gene |
| EZH2 | 2146 | PubTator's text mining | https://conductscience.org/library/genes/2146 | NCBI Gene |
| H3P16 | 644914 | PubTator's text mining | https://conductscience.org/library/genes/644914 | NCBI Gene |
| HDAC1 | 3065 | PubTator's text mining | https://conductscience.org/library/genes/3065 | NCBI Gene |
| HDAC2 | 3066 | PubTator's text mining | https://conductscience.org/library/genes/3066 | NCBI Gene |
| HDAC5 | 10014 | PubTator's text mining | https://conductscience.org/library/genes/10014 | NCBI Gene |
| HDAC9 | 9734 | PubTator's text mining | https://conductscience.org/library/genes/9734 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25757092
GET https://conductscience.org/api/papers/v1/25757092/authors